AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
US6902746B2
(en)
*
|
2002-07-03 |
2005-06-07 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same
|
FR2845917B1
(fr)
*
|
2002-10-21 |
2006-07-07 |
Negma Gild |
Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
|
US20040121004A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
WO2004064815A1
(en)
*
|
2003-01-21 |
2004-08-05 |
Smartrix Technologies Inc. |
Oral dosage formulation
|
WO2004096201A1
(en)
|
2003-04-29 |
2004-11-11 |
Orexigen Therapeutics, Inc. |
Compositions for affecting weight loss
|
KR100762846B1
(ko)
*
|
2003-09-29 |
2007-10-04 |
씨제이 주식회사 |
서방성 제제
|
WO2005030179A1
(en)
*
|
2003-09-29 |
2005-04-07 |
Cj Corporation |
Sustained-release formulations
|
WO2005074930A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Altana Pharma Ag |
Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
|
CA2554271A1
(en)
*
|
2004-02-10 |
2005-08-25 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
CA2566655C
(en)
*
|
2004-05-25 |
2013-04-16 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US20060002986A1
(en)
*
|
2004-06-09 |
2006-01-05 |
Smithkline Beecham Corporation |
Pharmaceutical product
|
WO2006137839A2
(en)
*
|
2004-08-24 |
2006-12-28 |
Merck & Co., Inc. |
Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
|
US20060045865A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
WO2006061351A1
(en)
*
|
2004-12-06 |
2006-06-15 |
Janssen Pharmaceutica N.V. |
Oral suspension comprising meloxicam
|
US20060165797A1
(en)
*
|
2005-01-12 |
2006-07-27 |
Pozen Inc. |
Dosage form for treating gastrointestinal disorders
|
US20060178349A1
(en)
*
|
2005-01-24 |
2006-08-10 |
Pozen Inc. |
Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID
|
CA2511158A1
(en)
*
|
2005-06-29 |
2006-12-29 |
Medical Futures Inc. |
Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against nsaid gastropathy
|
US20070043097A1
(en)
*
|
2005-07-18 |
2007-02-22 |
Horizon Therapeutics, Inc. |
Medicaments containing famotidine and ibuprofen and administration of same
|
US20080020040A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Unit dose form for administration of ibuprofen
|
US8067451B2
(en)
*
|
2006-07-18 |
2011-11-29 |
Horizon Pharma Usa, Inc. |
Methods and medicaments for administration of ibuprofen
|
US20080021078A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Horizon Therapeutics, Inc. |
Methods and medicaments for administration of ibuprofen
|
US20080166407A1
(en)
*
|
2005-07-29 |
2008-07-10 |
Shalaby Shalaby W |
Solid oral formulations for combination therapy
|
US20080085314A1
(en)
*
|
2005-07-29 |
2008-04-10 |
Shalaby Shalaby W |
Solid oral formulations for combination therapy
|
EP2135603B1
(en)
|
2005-11-22 |
2013-01-02 |
Orexigen Therapeutics, Inc. |
Compositions and methods for increasing insulin sensitivity
|
WO2007089318A2
(en)
*
|
2005-11-23 |
2007-08-09 |
Orexigen Therapeutics, Inc. |
Compositions and methods for reducing food cravings
|
AR057181A1
(es)
*
|
2005-11-30 |
2007-11-21 |
Astra Ab |
Nueva forma de dosificacion de combinacion
|
US20070154542A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Cogentus Pharmaceuticals, Inc. |
Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
|
US9265732B2
(en)
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
CN101460154B
(zh)
|
2006-04-04 |
2015-07-01 |
Kg艾克维泽生公司 |
包含抗血小板剂和抑酸剂的口服剂型
|
EP2015731B1
(en)
|
2006-04-28 |
2013-11-06 |
Wockhardt Limited |
Pharmaceutical compositions comprising non-steroidal antiinflammatory drug, acetaminophen and proton pump inhibitor
|
CH696229A5
(fr)
*
|
2006-05-13 |
2007-02-28 |
Professeur Dr Achille Benakis |
Nouvelles formes galéniques de l'Artemisinine et ses dérivés en association avec d'autres antipaludéens pour le traitement de la malaria.
|
US8916195B2
(en)
|
2006-06-05 |
2014-12-23 |
Orexigen Therapeutics, Inc. |
Sustained release formulation of naltrexone
|
GB0613925D0
(en)
*
|
2006-07-13 |
2006-08-23 |
Unilever Plc |
Improvements relating to nanodispersions
|
US20150224056A1
(en)
*
|
2006-07-18 |
2015-08-13 |
Horizon Pharma Usa, Inc. |
Pharmaceutical compositions of ibuprofen and famotidine
|
US8067033B2
(en)
*
|
2007-11-30 |
2011-11-29 |
Horizon Pharma Usa, Inc. |
Stable compositions of famotidine and ibuprofen
|
PL2043637T3
(pl)
*
|
2006-07-18 |
2012-06-29 |
Horizon Pharma Usa Inc |
Sposoby i leki do podawania ibuprofenu
|
US20100297224A1
(en)
*
|
2006-08-31 |
2010-11-25 |
Horizon Therapeutics, Inc. |
NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
|
TWI609702B
(zh)
|
2006-11-09 |
2018-01-01 |
歐瑞根治療有限公司 |
層狀醫藥調配物
|
KR20180066272A
(ko)
|
2006-11-09 |
2018-06-18 |
오렉시젠 세러퓨틱스 인크. |
단위 용량 팩키지
|
KR100885029B1
(ko)
*
|
2007-02-07 |
2009-02-23 |
지엘팜텍 주식회사 |
경구투여용 서방성 삼중정제
|
WO2008101064A1
(en)
*
|
2007-02-14 |
2008-08-21 |
Logical Therapeutics, Inc. |
Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and an h2 receptor antagonist
|
US20100305074A1
(en)
*
|
2007-04-04 |
2010-12-02 |
Hight H Thomas |
Niacin-based pharmaceutical compositions
|
WO2009012425A2
(en)
*
|
2007-07-19 |
2009-01-22 |
Logigal Therapeutics, Inc. |
Compositions including leukotriene antagonists and nsaids and methods of using the same
|
WO2009089134A1
(en)
*
|
2008-01-04 |
2009-07-16 |
Src, Inc. |
Methods for measuring a patint response upon administration of a drug and compositions thereof
|
US20090186086A1
(en)
*
|
2008-01-17 |
2009-07-23 |
Par Pharmaceutical, Inc. |
Solid multilayer oral dosage forms
|
WO2009118764A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Pharmaceutical composition comprising diclofenac and paracetamol
|
WO2009137648A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Aptapharma, Inc. |
Multilayer proton pump inhibitor tablets
|
US20090280173A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Omeprazole Tablets
|
MX2010012909A
(es)
|
2008-05-30 |
2011-02-25 |
Orexigen Therapeutics Inc |
Metodos para tratamiento de condiciones de grasa visceral.
|
KR20110079641A
(ko)
*
|
2008-09-09 |
2011-07-07 |
아스트라제네카 아베 |
제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
|
US8058296B2
(en)
*
|
2008-11-25 |
2011-11-15 |
Richard Tokunaga |
Treatment and prevention of deleterious effects associated with alcohol consumption
|
WO2010078542A1
(en)
*
|
2009-01-05 |
2010-07-08 |
Mcneil-Ppc, Inc. |
Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
|
CA2748728C
(en)
*
|
2009-01-05 |
2017-01-03 |
Mcneil-Ppc, Inc. |
Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
|
WO2010078541A1
(en)
*
|
2009-01-05 |
2010-07-08 |
Mcneil-Ppc, Inc. |
Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
|
US20100305163A1
(en)
*
|
2009-05-20 |
2010-12-02 |
Pramod Dattatray Yedurkar |
Pharmaceutical formulations comprising nsaid and proton pump inhibitor drugs
|
US20120064159A1
(en)
*
|
2009-05-28 |
2012-03-15 |
Aptapharma, Inc. |
Multilayer Oral Tablets Containing a Non-Steroidal Anti-Inflammatory Drug and/or Acetaminophen
|
CA2766524A1
(en)
*
|
2009-06-25 |
2010-12-29 |
Pozen Inc. |
Method for treating a patient in need of aspirin therapy
|
AU2010263304A1
(en)
*
|
2009-06-25 |
2012-02-02 |
Astrazeneca Ab |
Method for treating a patient at risk for developing an NSAID-associated ulcer
|
CN102711835B
(zh)
*
|
2009-11-27 |
2014-12-10 |
努沃研究股份有限公司 |
局部布洛芬制剂
|
RU2616496C2
(ru)
|
2010-01-11 |
2017-04-17 |
Ориксиджен Терапьютикс, Инк. |
Способы проведения терапии потери веса у пациентов с доминирующей депрессией (варианты)
|
KR20130098320A
(ko)
|
2010-08-04 |
2013-09-04 |
토마스 줄리어스 보로디 |
분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
|
MY180677A
(en)
|
2010-12-03 |
2020-12-05 |
Takeda Pharmaceuticals Co |
Orally disintegrating tablet
|
MX355760B
(es)
|
2010-12-13 |
2018-04-27 |
Salix Pharmaceuticals Inc |
Formulaciones gástricas y colónicas y métodos para elaborar y usar las mismas.
|
EP2683390B1
(en)
|
2011-03-09 |
2017-05-03 |
Regents Of The University Of Minnesota |
Compositions and methods for transplantation of colon microbiota
|
WO2012173581A1
(en)
|
2011-03-21 |
2012-12-20 |
Ak Kimya Ithalat-Ihracat Ve Sanayii A.S. |
Thiocolchicoside, etodolac and famotidine combinations
|
TR201103752A2
(tr)
|
2011-04-18 |
2012-11-21 |
Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. |
Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.
|
JP2014516080A
(ja)
*
|
2011-06-08 |
2014-07-07 |
エスティーアイ ファーマ, エルエルシー |
一日一回の投与のための吸収が制御された水溶性の薬学的に活性な有機化合物製剤
|
WO2013054352A1
(en)
|
2011-08-17 |
2013-04-18 |
Cadila Healthcare Limited |
Pharmaceutical compositions of ibuprofen and famotidine
|
CN102247369B
(zh)
*
|
2011-08-18 |
2012-11-21 |
天津市嵩锐医药科技有限公司 |
复方萘普生埃索美拉唑药物组合物及其制备方法
|
CN102247371A
(zh)
*
|
2011-08-19 |
2011-11-23 |
北京阜康仁生物制药科技有限公司 |
一种以布洛芬和拉呋替丁为活性成分的药物组合物
|
CN103906506A
(zh)
|
2011-09-14 |
2014-07-02 |
波曾公司 |
氯吡格雷与胃酸抑制治疗的控制给药
|
MY186477A
(en)
|
2011-11-30 |
2021-07-22 |
Takeda Pharmaceuticals Co |
Dry coated tablet
|
EP2797600A4
(en)
|
2011-12-28 |
2015-09-16 |
Pozen Inc |
IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
CN110170050A
(zh)
|
2012-06-04 |
2019-08-27 |
高拉夫·阿格拉沃尔 |
用于治疗克罗恩氏病和相关病况以及感染的组合物和方法
|
WO2013184837A1
(en)
|
2012-06-06 |
2013-12-12 |
Orexigen Therapeutics, Inc. |
Methods of treating overweight and obesity
|
WO2014007778A1
(en)
*
|
2012-07-05 |
2014-01-09 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
COMBINED IMMEDIATE RELEASE FORMULATIONS OF NSAIDs
|
WO2014007777A1
(en)
|
2012-07-05 |
2014-01-09 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Combined capsule formulations of nsaids
|
DK2877163T3
(da)
|
2012-07-27 |
2019-04-15 |
Redhill Biopharma Ltd |
Formuleringer og fremgangsmåder til fremstilling af formuleringer til anvendelse af tarmtømning
|
US20160089363A1
(en)
|
2013-04-30 |
2016-03-31 |
Thomas Julius Borody |
Compositions and methods for treating microbiota-related psychotropic conditions and diseases
|
SI3086793T1
(sl)
|
2013-12-24 |
2022-10-28 |
Virginia Commonwealth University |
Uporaba oksigeniranih holesterol sulfatov (OCS) za zdravljenje ledvične disfunkcije
|
WO2015150943A1
(en)
*
|
2014-03-29 |
2015-10-08 |
Wockhardt Limited |
Pharmaceutical composition of nsaid and ppi or salt thereof
|
KR101723266B1
(ko)
|
2014-08-13 |
2017-04-05 |
영남대학교 산학협력단 |
비스테로이드성 항염증약물 및 프로톤 펌프 저해제를 포함하는 경구용 속방형 조성물 및 그 제조방법
|
EP3236954B1
(en)
*
|
2014-12-23 |
2022-03-23 |
DuPont Nutrition USA, Inc. |
Enteric film coating compositions, method of coating, and coated forms
|
US10821181B2
(en)
|
2015-02-10 |
2020-11-03 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10058614B2
(en)
|
2015-02-10 |
2018-08-28 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11013805B2
(en)
|
2015-02-10 |
2021-05-25 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11738085B2
(en)
|
2015-02-10 |
2023-08-29 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10537642B1
(en)
|
2015-02-10 |
2020-01-21 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10780165B2
(en)
|
2015-02-10 |
2020-09-22 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11110173B2
(en)
|
2015-02-10 |
2021-09-07 |
Axsome Therapeutics, Inc |
Pharmaceutical compositions comprising meloxicam
|
US10729774B1
(en)
|
2015-02-10 |
2020-08-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10758618B2
(en)
|
2015-02-10 |
2020-09-01 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10722583B2
(en)
|
2015-02-10 |
2020-07-28 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10729773B2
(en)
|
2015-02-10 |
2020-08-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11607456B2
(en)
|
2015-02-10 |
2023-03-21 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10532101B1
(en)
|
2015-02-10 |
2020-01-14 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10933136B2
(en)
|
2015-02-10 |
2021-03-02 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10780166B2
(en)
|
2015-02-10 |
2020-09-22 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10695430B2
(en)
|
2015-02-10 |
2020-06-30 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10653777B2
(en)
|
2015-02-10 |
2020-05-19 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10695429B2
(en)
|
2015-02-10 |
2020-06-30 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10933137B2
(en)
|
2015-02-10 |
2021-03-02 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10799588B2
(en)
|
2015-02-10 |
2020-10-13 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11602563B2
(en)
|
2015-02-10 |
2023-03-14 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10517950B1
(en)
|
2015-02-10 |
2019-12-31 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11045549B2
(en)
|
2015-02-10 |
2021-06-29 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10702602B2
(en)
|
2015-02-10 |
2020-07-07 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10512692B2
(en)
|
2015-02-10 |
2019-12-24 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11013806B2
(en)
|
2015-02-10 |
2021-05-25 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
EP3294307A4
(en)
|
2015-05-14 |
2019-01-23 |
Crestovo Holdings Llc |
COMPOSITIONS FOR TRANSPLANTATION OF FECAL FLORA AND METHODS OF PREPARATION AND USE THEREOF, AND DEVICES FOR THEIR ADMINISTRATION
|
NZ776366A
(en)
|
2015-05-22 |
2023-02-24 |
Univ Minnesota |
Methods for treating autism spectrum disorder and associated symptoms
|
TWI710379B
(zh)
*
|
2015-07-30 |
2020-11-21 |
日商武田藥品工業股份有限公司 |
錠劑
|
EP3352773A4
(en)
|
2015-09-24 |
2019-03-27 |
San Diego State University (SDSU) Foundation DBA San Diego State University Research Foundation |
ANTIBACTERIAL AND PROTECTIVE BACTERIOPHAGE FORMULATIONS AND PROCESS FOR THE PREPARATION AND USE THEREOF
|
EP4008319A1
(en)
*
|
2015-11-25 |
2022-06-08 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
WO2018004498A1
(en)
|
2016-06-30 |
2018-01-04 |
Imuneks Farma Ilac San. Ve Tic. A.S. |
Nsaid and h2 receptor antagonist combinations for the treatment of pain and inflammation
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
WO2018071537A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US11213549B2
(en)
|
2016-10-11 |
2022-01-04 |
Finch Therapeutics Holdings Llc |
Compositions and method for treating primary sclerosing cholangitis and related disorders
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
TR201717134A2
(tr)
|
2016-12-07 |
2018-07-23 |
Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi |
Ağrı Ve Enflamasyonun Hızlı Tedavisi İçin Diklofenak Ve H2 Reseptör Antagonistlerinin Çabuk Salımlı Oral Kombinasyonları
|
TR201618765A2
(tr)
|
2016-12-16 |
2018-07-23 |
Imuneks Farma Ilac Sanayi Ve Ticaret Anonim Sirketi |
Ağrı ve enflamasyonun tedavisi için steroid olmayan anti-enflamatuvar ilaçlar ve H2 reseptörü antagonisti kombinasyonları.
|
US10583088B2
(en)
|
2017-01-04 |
2020-03-10 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10561664B1
(en)
|
2017-01-04 |
2020-02-18 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10905693B2
(en)
|
2017-01-04 |
2021-02-02 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11433078B2
(en)
|
2017-01-04 |
2022-09-06 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11806354B2
(en)
|
2017-01-04 |
2023-11-07 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10583144B2
(en)
|
2017-01-04 |
2020-03-10 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10729697B2
(en)
|
2017-01-04 |
2020-08-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11433079B2
(en)
|
2017-01-04 |
2022-09-06 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11617755B2
(en)
|
2017-01-04 |
2023-04-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10940153B2
(en)
|
2017-01-04 |
2021-03-09 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11801250B2
(en)
|
2017-01-04 |
2023-10-31 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11266657B2
(en)
|
2017-01-04 |
2022-03-08 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
KR20190122659A
(ko)
|
2017-01-04 |
2019-10-30 |
액섬 테라퓨틱스, 인크. |
멜록시캄을 포함하는 약학적 조성물
|
US10894053B2
(en)
|
2017-01-04 |
2021-01-19 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11207327B2
(en)
|
2017-01-04 |
2021-12-28 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10471014B2
(en)
|
2017-01-04 |
2019-11-12 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11471465B2
(en)
|
2017-01-04 |
2022-10-18 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10821182B2
(en)
|
2017-06-29 |
2020-11-03 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10729696B2
(en)
|
2017-01-04 |
2020-08-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
WO2018187464A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
AU2018250206A1
(en)
|
2017-04-05 |
2019-10-31 |
Crestovo Holdings Llc |
Compositions and methods for treating parkinson's disease (PD) and related disorders
|
AU2018272048B2
(en)
|
2017-05-26 |
2024-04-04 |
Finch Therapeutics Holdings Llc |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
US11185550B2
(en)
|
2017-06-29 |
2021-11-30 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11617756B2
(en)
|
2017-06-29 |
2023-04-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11865117B2
(en)
|
2017-06-29 |
2024-01-09 |
Axsome Therapeutics, Inc |
Pharmaceutical compositions comprising meloxicam
|
US10987358B2
(en)
|
2017-06-29 |
2021-04-27 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11219626B2
(en)
|
2017-06-29 |
2022-01-11 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10688185B2
(en)
|
2017-06-29 |
2020-06-23 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11510927B2
(en)
|
2017-06-29 |
2022-11-29 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10758617B2
(en)
|
2017-06-29 |
2020-09-01 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11617791B2
(en)
|
2017-06-29 |
2023-04-04 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10918722B2
(en)
|
2017-06-29 |
2021-02-16 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US11759522B2
(en)
|
2017-06-29 |
2023-09-19 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10512693B2
(en)
|
2017-06-29 |
2019-12-24 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
US10688102B2
(en)
|
2017-06-29 |
2020-06-23 |
Axsome Therapeutics, Inc. |
Combination treatment for migraine and other pain
|
US10350171B2
(en)
|
2017-07-06 |
2019-07-16 |
Dexcel Ltd. |
Celecoxib and amlodipine formulation and method of making the same
|
EP3664823B1
(en)
|
2017-08-07 |
2024-06-05 |
Finch Therapeutics Holdings LLC |
Composition for use in preventing or treating an enterococcal blood stream infection
|
TR201718099A2
(tr)
|
2017-11-16 |
2019-06-21 |
Mehmet Nevzat Pisak |
Ağri ve enflamasyonun tedavi̇si̇ i̇çi̇n di̇klofenak, h2 reseptör antagoni̇stleri̇ ve alkali̇ metal bi̇karbonatlarindan olusan kombi̇nasyonlar
|
WO2019135725A1
(en)
|
2018-01-03 |
2019-07-11 |
Pisak Mehmet Nevzat |
Combinations of selective cox-2 inhibitor nsaids and h2 receptor antagonists for fast treatment of pain and inflammation
|
WO2020013781A2
(en)
*
|
2018-03-27 |
2020-01-16 |
Pisak Mehmet Nevzat |
Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation
|
EA202092800A1
(ru)
*
|
2018-05-28 |
2021-04-08 |
Мехмет Невзат Писак |
Фармацевтическая композиция немедленного высвобождения для противовоспалительных лекарственных средств с фамотидином и карбонатом
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
CA3114423A1
(en)
|
2018-09-27 |
2020-04-02 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
CA3124579A1
(en)
|
2020-07-15 |
2022-01-15 |
Schabar Research Associates Llc |
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
|
AU2021310264A1
(en)
|
2020-07-15 |
2023-02-09 |
Schabar Research Associates Llc |
Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
|
US20220125732A1
(en)
*
|
2020-10-23 |
2022-04-28 |
Appco Pharma Llc |
Ibuprofen and famotidine tablet
|
WO2022147155A1
(en)
|
2020-12-31 |
2022-07-07 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|
WO2023079094A1
(en)
|
2021-11-05 |
2023-05-11 |
Cinclus Pharma Holding AB (publ) |
Polymorphs of the hydrochloride salt of linaprazan glurate
|
US12005118B2
(en)
|
2022-05-19 |
2024-06-11 |
Axsome Therapeutics, Inc. |
Pharmaceutical compositions comprising meloxicam
|